TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

269 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

ListMap
Weight & metabolicPeptide & GLP-1Mental healthLungs & breathingHeart & circulationKidneyBrain & memoryBlood disordersImmune & autoimmuneSkin

150 studies on the map

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) — Phoenix Children's Hospital, PhoenixA Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) — University of Arizona, TucsonGATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes — Medical Investigations, Little RockTrial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Arizona Clinical Trials - Pecos, ChandlerA Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus — Central Research Associates - Flourish - PPDS, BirminghamA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Lakeview Clinical Research, GuntersvilleA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide — Helios Clinical Research - Phoenix, PhoenixA Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Clinical Research Institute of Arizona, Sun City WestEvaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes — Sansum Diabetes Research Institute, Santa BarbaraA Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) — CenExel Anaheim Clinical Trials, AnaheimA Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. — Research Site, SurpriseHP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes — Alliance Clinical Canoga Park (Hope Clinical Research), Canoga ParkA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Uni of Alabama at Birmingham, BirminghamEfficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System — University of Southern California, Los AngelesSafety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes — University of Alabama, BirminghamSPYRAL GEMINI Pilot Study — Stanford Hospital and Clinics, StanfordProact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease — Nephrology Consultants, HuntsvilleA Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies — Research Site, Little RockA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure — Research Site, FairhopePhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy — Central Research Associates, LLC dba Flourish Research, BirminghamPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets — Central Research Associates, LLC dba Flourish Research, BirminghamStudy to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus — Lenzmeier Family Medicine, GlendaleCGM for Management of Type 2 Diabetes in Pregnancy — University of Alabama at Birmingham, BirminghamEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Pinnacle Research Group, LLC, AnnistonA Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM — Clinical Trial Site, MontclairImplementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) — University of Alabama, BirminghamImplementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD) — University of Alabama, BirminghamBalance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems — OrthoArizona--Mesa Arbor Avenue, MesaBreathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH — Rocky Mountain Regional VA Medical Center, Aurora, CO, AuroraEfficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus — Lynn Institute of the Ozarks, Little RockA Study of LY3971297 in Healthy Participants — CenExel ACT, AnaheimSafety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes — SUNY Upstate Medical Center, AlbanyMilitary Health and Nutrition Examination Study — Fort Campbell, Fort CampbellA Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities — Unity Health Care, Washington D.C.Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) — Washington University School of Medicine, St LouisRole of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes — University of Colorado, AuroraPuberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study) — Children's Hospital Colorado, AuroraStudy of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D — Clinical Pharmacology of Miami, MiamiYouth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study — Children's National Hospital (CNH), Washington D.C.Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification — University of Colorado Department of Family Medicine, AuroraCGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes — Jefferson Health New Jersey, SewellPrimary Care Pragmatic, Real World Experience for Automated Insulin Delivery — University of Colorado Anschutz Medical Campus, AuroraExercise and Intranasal Insulin in Type 2 Diabetes — Robert Wood Johnson University Hospital Clinical Research Center, New BrunswickFood and Fitness With Medicine (FFWM) — Ohio State Healthy Community Center, ColumbusExtracellular Vesicles, Insulin Action, and Exercise — Institute for Food, Nutrition, and Health, New BrunswickA Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors — UConn Health, FarmingtonIntegrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure — Johns Hopkins Community Physicians, BaltimoreStudy to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency — Syneos Miami, MiamiSocial Needs Screening and Chronic Diseases Study (WE CARE) — UMass Memorial Medical Center - Hahnemann Campus, WorcesterDietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy — University South Carolina, ColumbiaThe Sweet Kids Study (Stevia on Weight and Energy Effect Over Time) — Arkansas Children's Nutrition Center, Little RockDiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes — Childrens hospital colorado, DenverPrecision Dosing of Metformin in Youth With T2D — UCSF Benioff Children's Hospital Oakland, Pediatric Diabetes Clinic, OaklandComparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes — University Health System Texas Diabetic Institute, San AntonioEnhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients — One Robert Wood Johnson Place, New BrunswickImproving Appetite Self-Regulation in African American Adults With Type 2 Diabetes — Rachel W. Goode, KannapolisAddressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US — Duke University - Charlotte Study Sites, CharlotteNormal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide — Stanford University, Palo AltoQuantifying Hepatic Mitochondrial Fluxes in Humans — Texas Diabetes Institute - University Health System, San AntonioGlycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes — University Health - Texas Diabetic Institute, San AntonioImplementation of Team Clinic for Type 2 Diabetes (TCT2) — Children's Hospital Los Angeles, Los AngelesVirtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy — Rutgers Health Family Medicine at Monument Square, New BrunswickEnhancing Diabetes Care: Exposome &Amp; Sensors — University of Illinois - Chicago, ChicagoEvaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care. — WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus ChristiPharmacy-led Transitions of Care Intervention to Improve Medication Adherence — University of Tennessee Medical Center, KnoxvilleCocooned Moms Study — University Of Miami, MiamiHealthy Living Anson Study — University of North Carolina at Chapel Hill, Chapel HillGut Microbiota in Metabolic Surgery — Vanderbilt_University MC, NashvilleLifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients — West Virginia School of Osteopathic Medicine, LewisburgHigh Fructose Diet, the Gut Microbiome, and Metabolic Health — Mount Sinai Morningside, New YorkSympathetic Mechanisms in Obesity-Crossover Design — Vanderbilt University Medical Center, NashvillePRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis — University of Alabama at Birmingham, BirminghamCardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension — Penn State Milton S. Hershey Medical Center, HersheyFeasibility of Semaglutide in Advanced Lung Disease — University of Pennsylvania Perelman School of Medicine, PhiladelphiaMetabolic Effects of Angiotensin-(1-7) — Vanderbilt University Medical Center, NashvilleEffects of HIIT vs. TRE on Type 2 Diabetes Risk — Syracuse University, SyracuseSympathetic Transduction in Obesity-associated Hypertension (OB-HTN) — University of Texas Southwestern Medical Center, DallasCommunity Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study — Miami-Dade County Parks, Recreation and Open Spaces Department, MiamiInspire HER: Inspiring the Heart and Emotions for Radical Health — University of Alabama at Birmingham, BirminghamPioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants — Texas Diabetes Institute/UH, San AntonioExercise and Protein Efficiency in T2D — Freer Hall - University of Illinois, UrbanaBrown Adipose Tissue Activation by Spinal Cord Stimulation — Oregon Health & Science University, PortlandTargeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial — Sidney & Lois Eskenazi Hospital, IndianapolisCommunity Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study — Miami-Dade County Parks, Recreation and Open Spaces Department, MiamiNon-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health. — Clindove Research LLC, BrooklynKetogenic Diet and Diabetes Demonstration Project — University of New Mexico, AlbuquerqueNutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics — Joslin Diabetes Center, BostonSympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study) — University of Kansas Medical Center, Kansas CityCircadian Intervention to Improve Cardiometabolic Health — College of Health Research Complex--University of Utah, Salt Lake CityUnderstanding Metabolism and Inflammation Risks for Diabetes in Adolescents — University of Michigan, Ann ArborOptimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease — Cleveland Clinic Main Campus, ClevelandFacilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions — Massachusetts General Hospital, BostonPediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) — Wake Forest Health Sciences, Winston-SalemPrescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults — Kennesaw State Universityh, KennesawRole of KATP Channel Loss in Type 2 Diabetes — Washington University in St. Louis, St LouisConical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients — Prentice Women's Hospital, ChicagoImpact GLP-1 Agonists Following Bariatric — University of Missouri Hospital, ColumbiaAdapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents — USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, HoustonDietary Insights and Nutritional Education in Adults on GLP-1 Therapy — University South Carolina, ColumbiaDiabetes Reversal Online Program and Study (DROP Study) — Physician Committee for Responsible Medicine, Washington D.C.Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy — State University of New York at Buffalo, South Campus, BuffaloDiabetes and Heart Disease Risk in Blacks — National Institutes of Health Clinical Center, BethesdaPreparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors — University of Illinois Chicago, ChicagoHealth Without Barriers/Salud Sin Barreras- Northern Colorado — Colorado State University, Fort CollinsCARBON: UAB Cardiovascular Research Biobank — University of Alabama at Birmingham, BirminghamMitigating the Pro-inflammatory Phenotype of Obesity — University of Kansas Medical Center, Kansas CityBlack Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention — The Ohio State University, ColumbusTime Limited Eating in Adolescents With Type 2 Diabetes (KT2D) — Children's Hospital of Los Angeles, Los AngelesSisters for Heart Health: A Community Health Worker Initiative for Improving Heart Health in Farmworker Women — Southern GA - Colquitt County, EllentonCommunity Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study — Miami-Dade County Parks, Recreation and Open Spaces Department, MiamiEffect of Sleep Extension on Ceramides in People with Overweight and Obesity — College of Health Research Complex--University of Utah, Salt Lake CityThe Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART) — Temple University/Temple Health, PhiladelphiaPATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents — Children's Nutrition Research Center, HoustonPreventing Type 2 Diabetes in Black Emergent Adult — UNC-Chapel Hill, Chapel HillUric Acid Lowering Trial in Youth Onset T2D — Children's Hospital Colorado, AuroraType 2 Continuous Glucose Monitoring Academy — Children's Hospital Los Angeles, Los AngelesThe Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes — Mayo Clinic in Rochester, RochesterMechanisms of Fatigability With Diabetes — University of Michigan, Ann ArborContinuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge — Vanderbilt University Medical Center, NashvilleThe Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults — Translational Research Institute for Metabolism and Diabetes, OrlandoAchieving Routine Intervention and Screening for Emotional Health — University of Chicago, ChicagoUltrasound Effects on Glycemic Control in T2DM — Yale-New Haven Hospital, New HavenWhey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals — University of Arkansas for Medical Sciences, Little RockThe GRoceries Aimed at Increasing Nutrition Study — University of Pennsylvania, PhiladelphiaJoint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes — Medical College of Wisconsin, MilwaukeeFitbit and AI Chatbot in Sedentary Primary Care Patients With T2D — University of Colorado, Anschutz, AuroraAssessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions — UT Southwestern Medical Center, DallasRole of Autophagy in Type 2 Diabetes Microvascular Dysfunction — Medical College of Wisconsin, MilwaukeeRCT Glargine vs NPH for Treatment of DM in Pregnancy — Loyola University Medical Center, MaywoodTHC Effects on Glucose in Type 2 Diabetes — UC San Diego Altman Clinical & Translational Research Institute, La JollaA Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients — University of Alabama at Birmingham/ Children's of Alabama, BirminghamDigital Health Navigation for Latino Patients With Type II Diabetes — Brigham and Women's Hospital, BostonACCESS 2: AI for pediatriC diabetiC Eye examS Study 2 — Johns Hopkins Pediatric Diabetes Center, BaltimoreEffect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT — Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), TorrancePersonalized Nutrition for Type 2 Diabetes — University of Minnesota, MinneapolisIH, Brain Health, and T2D — University of Iowa, Iowa CityLINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes — NYU Langone Health, New YorkPeanuts for Cardiometabolic, Brain, and Intestinal Health — Georgia State University, AtlantaMechanism of SGLT2 Inhibition in the Kidney — University of Michigan, Ann ArborPreventing T2DM After GDM With Immediate Postpartum Screening — University of Massachusetts Memorial Medical Center, WorcesterSGLTi, Hepatic Glucose Production and Ketogenesis — Texas Diabetes Institute/UH, San AntonioCulturally Tailored Program for Food-Insecure Adults: SPICE-D — Wake Forest University Health Sciences, Winston-SalemContinuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access — Fair Haven Community Health Care (FHCHC), New HavenPilot of Continuous Glucose Monitor-Augmented Food Is Medicine — University of North Carolina at Chapel Hill, Chapel HillA Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes — Clinical Pharmacology of Miami, MiamiRandomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy — Serena Group- Monroeville, MonroevilleSGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia — Texas Diabetes Institute/UH, San AntonioContinuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes — Cleveland Clinic Foundation, ClevelandSubclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease — Brigham and Women's Hospital, BostonGlycemic Excursion Minimization (GEM) to Outshine Health Disparities — Georgia Prevention Institute, Augusta

Showing the 150 nearest — narrow your filters for fewer, closer studies.